XACTUS ONCO Trademark

Trademark Overview


On Tuesday, October 17, 2023, a trademark application was filed for XACTUS ONCO with the United States Patent and Trademark Office. The USPTO has given the XACTUS ONCO trademark a serial number of 79384345. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by XACTUS Onco Co., Ltd.. The XACTUS ONCO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; development of cell therapy products; drug discovery services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; research and development of amino acid for medical purpose; research and development of peptide for medical purposes; research and development of technology for medicinal chemical manufacturing; analysis and evaluation of medical product development services to determine conformity with established accreditation standards; scientific research in the fields of medicine, health and pharmacology; industrial research in the fields of medicine, health and pharmacology; medical and scientific research, namely, conducting clinical trials for others
xactus onco

General Information


Serial Number79384345
Word MarkXACTUS ONCO
Filing DateTuesday, October 17, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Description of MarkThe mark consists of a dark green stylized cactus design to the left of the stylized wording "XACTUS ONCO" in which the "X" is dark green and red, "ACTUS" is dark green, and "ONCO" is gray.
Indication of Colors claimedThe color(s) dark green, red and gray is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of vaccines and medicines; development of cell therapy products; drug discovery services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; research and development of amino acid for medical purpose; research and development of peptide for medical purposes; research and development of technology for medicinal chemical manufacturing; analysis and evaluation of medical product development services to determine conformity with established accreditation standards; scientific research in the fields of medicine, health and pharmacology; industrial research in the fields of medicine, health and pharmacology; medical and scientific research, namely, conducting clinical trials for others

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXACTUS Onco Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR

Party NameXACTUS Onco Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events


Event DateEvent Description
Thursday, November 30, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 5, 2023APPLICATION FILING RECEIPT MAILED
Saturday, May 25, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 3, 2024ASSIGNED TO EXAMINER
Thursday, June 6, 2024NON-FINAL ACTION WRITTEN
Saturday, June 15, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 29, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 29, 2024REFUSAL PROCESSED BY MPU
Saturday, July 20, 2024REFUSAL PROCESSED BY IB
Friday, September 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED